PROF FARHAT BASHIR
DEPARTMENT OF MEDICINE
UM&DC AND CGH
• Fungi are eukaryotes with cell walls that
give them their shape.
• Fungal cells can grow as a multicellular
filaments called moulds Or as single cells or
chains of cells called yeast.
ACCORDING TO PATHOGENICITY:
• Superficial mycoses/Mucocutaneous mycoses
• Subcutaneous mycoses
• Deep mycoses/SYSTEMIC MYCOSIS
SPECIMEN COLLECTION:
SKIN SCRAPINGS
o Nail clippings/scrapings
o Hair
o Exudates
o Biopsy materials.
o Respiratory .
o Body fluids e.g CSF.
DIRECT EXAMINATION: Wood’s lamp
10-30% KOH
Histological stains- H&E, PAS
India Ink
Wet mount
II. Isolation & Culture
SDA
Media with/without antibiotics
 Macroscopic examination of culture
 Microscopic examination
Topical anti-fungal
Systemic anti-fungal
 Associated with:
• Skin
• Eyes
• Sinuses
• Oropharynx and external ears
• Vagina
common and limited to the very superficial
or keratinized layers of skin, hair, and nails.
 Dermatophyte (Ringworm) – skin lesions
characterized by red margins, scales and
itching.
 onychomycosis – chronic infection of the
nail
 Mucocutaneous candidiasis – colonization of
the mucous membranes
• Caused by the yeast Candida albicans
• Often associated with a loss of
immunocompetence
• Thrush – fungal growth in the oral cavity.
• Vulvovaginitis – fungal growth in the vaginal
canal
 Can be associated with a hormonal
imbalance e.g diabetes mellitus
 Localized primary infections of subcutaneous
tissue:involve lymphatics and rarely
disseminate
Can cause the development of cysts and
granulomas.
• Chromoblastomycosis
• Mycetoma – Eumycetoma,
actinomyecetoma
• Sporotrichosis – traumatic
implantation of fungal organisms.
• .
 Deep mycoses Usually seen in
immunosuppressed patients with:
• AIDS
• Cancer
• Diabetes
 Can be acquired by:
• Inhalation of fungi or fungal spores
• Use of contaminated medical equipment
 Deep mycoses can cause a systemic infection –
disseminated mycoses
Deep/systemic mycoses
1. Fever with severe neutropenia or
immunosuppresion
2. Fever resistant to broad spectrum
antibiotics in neutropenic patient
3. Symptoms and signs of new resistant or
progressive lower respiratory tract
infection
4. Prolonged severe lymphocytopenia in
chronic graft versus host disease [GVHD]
and immunosuppression
5. Periorbital or maxillary swelling with
tenderness
37
6. Palatal necrosis or perforation
7. Features of focal neurologic deficit or
meningeal irritation with fever
8. Unexplained mental changes with fever
9. Papular or nodular skin lesions
10. Intra-ocular evidence of systemic
fungal infection
38
Candidiasis
• Usually opportunistic and endogenous
originating from oropharyngeal, genitourinary or
skin colonization
• May be nosocomial
Acute disseminated
Chronic disseminated (hepatosplenic)
 Coccidiomycoses – caused by genus
Coccidioides.
• Primary respiratory infection.
• Leads to fever, erythremia, and bronchial
pneumonia.
• Usually resolves spontaneously due to immune
defense.
• Some cases are fatal.
 Histoplasmosis – caused by Histoplasma
capsulatum
• Often associated with immunodeficiency.
• Causes the formation of granulomas.
• Can necrotize and become calcified.
• If disseminated can be fatal.
 Aspergillosis – caused by several species of
Aspergillus
• Associated with immunodeficiency.
• Can be invasive and disseminate to the blood
and lungs
 Causes acute pneumonia
• Mortality is very high.
 Death can occur in weeks.
 Candidiasis.
 Dermatomycoses
Mucormycosis
Respiratory Fungal Infections-
Aspergillosis
Etioliogical agent: Candida albicans
• Dimorphic fungus of the class
Deuteromycetes .
 Grows as yeast or pseudohyphae
 Spread by contact; often part of normal flora
 Opportunistic infections common. Vulvovaginitis
 Oral candidiasis (thrush)
 Systemic candidiasis
Candidiasis
• Residing normally in the skin, mouth,
gastrointestinal tract, and vagina.
• DIABETICS AND BURN PATIENTS
susceptible to superficial candidiasis.
• Severe disseminated candidiasis: commonly
occurs in patients who are neutropenic due to
Leukemia, Chemotherapy, Or Bone Marrow
Transplantation, and may cause shock and DIC.
Types of candidiasis
Oral candidiasis (Thrush).
Perlèche (Angular cheilitis).
Candidal vulvovaginitis .
Diaper candidiasis.
Congenital cutaneous candidiasis .
Perianal candidiasis .
Candidal paronychia .
Erosio interdigitalis .
Chronic mucocuntaneous candidiasis .
Systemic candidiasis.
Antibiotic candidiasis (Iatrogenic candidiasis)
 commonly candidiasis takes the form of a
superficial infection on mucosal surfaces of
the oral cavity (thrush):
 Clinical features Oral thrush:
it is a sore mouth, shows white curd like
patches of the fungus on the oral mucosa and
tongue, which can be scrapped away leaving a
raw, tender, bleeding surface behind
1. Topical antifungal agents
Polyenes :Amphotericin B nystatin.
Imidazoles: Clotrimazole Miconazole
econazole
 2. Systemic antifungal agents :triazoles
Fluconazole , itraconazole
 Dermatomycoses are any fungal infection
of the skin or hair.
 Caused by many different species and are
generally named after the infected area
rather than the species that causes it.
Cause: Several genera of dermatophytic fungi:
• Trichophyton.
• Microsporum.
• Epidermophyton.
• Grow on skin, hair, nails
• Transmitted by contact with infected persons or
animals.
• Tinea pedis
• Tinea corporis
• Tinea capitis
• Tinea barbae
• Tinea cruris
• Tinea unguium/onychomycosis
Tinea infections: Red, scaly or blister-like lesions;
often a raised red ring; “ringworm”
 TOPICAL THERAPY: should be applied for at
least 2 weeks.
 Topical azoles and allylamines high rates of
clinical efficacy. (miconazole/ terbinafin)
 These agents inhibit the synthesis of
ergosterol, a major fungal cell membrane
sterol.
 SYSTEMIC THERAPY: may be indicated for
tinea corporis in extensive skin infection,
immunosuppression, resistance to topical
antifungal therapy.
Malassezia furfur
62
Eyes see
only
what
brain
thinks
Commo
n things
are
common
Think
“horses”
not
“zebras”
Analysis
improve
s patient
care

Fungal infections lec

  • 1.
    PROF FARHAT BASHIR DEPARTMENTOF MEDICINE UM&DC AND CGH
  • 2.
    • Fungi areeukaryotes with cell walls that give them their shape. • Fungal cells can grow as a multicellular filaments called moulds Or as single cells or chains of cells called yeast.
  • 16.
    ACCORDING TO PATHOGENICITY: •Superficial mycoses/Mucocutaneous mycoses • Subcutaneous mycoses • Deep mycoses/SYSTEMIC MYCOSIS
  • 18.
    SPECIMEN COLLECTION: SKIN SCRAPINGS oNail clippings/scrapings o Hair o Exudates o Biopsy materials. o Respiratory . o Body fluids e.g CSF. DIRECT EXAMINATION: Wood’s lamp 10-30% KOH Histological stains- H&E, PAS India Ink Wet mount
  • 20.
    II. Isolation &Culture SDA Media with/without antibiotics  Macroscopic examination of culture  Microscopic examination
  • 23.
  • 24.
     Associated with: •Skin • Eyes • Sinuses • Oropharynx and external ears • Vagina
  • 25.
    common and limitedto the very superficial or keratinized layers of skin, hair, and nails.  Dermatophyte (Ringworm) – skin lesions characterized by red margins, scales and itching.  onychomycosis – chronic infection of the nail
  • 27.
     Mucocutaneous candidiasis– colonization of the mucous membranes • Caused by the yeast Candida albicans • Often associated with a loss of immunocompetence • Thrush – fungal growth in the oral cavity. • Vulvovaginitis – fungal growth in the vaginal canal  Can be associated with a hormonal imbalance e.g diabetes mellitus
  • 29.
     Localized primaryinfections of subcutaneous tissue:involve lymphatics and rarely disseminate Can cause the development of cysts and granulomas.
  • 30.
    • Chromoblastomycosis • Mycetoma– Eumycetoma, actinomyecetoma • Sporotrichosis – traumatic implantation of fungal organisms. • .
  • 35.
     Deep mycosesUsually seen in immunosuppressed patients with: • AIDS • Cancer • Diabetes  Can be acquired by: • Inhalation of fungi or fungal spores • Use of contaminated medical equipment  Deep mycoses can cause a systemic infection – disseminated mycoses Deep/systemic mycoses
  • 37.
    1. Fever withsevere neutropenia or immunosuppresion 2. Fever resistant to broad spectrum antibiotics in neutropenic patient 3. Symptoms and signs of new resistant or progressive lower respiratory tract infection 4. Prolonged severe lymphocytopenia in chronic graft versus host disease [GVHD] and immunosuppression 5. Periorbital or maxillary swelling with tenderness 37
  • 38.
    6. Palatal necrosisor perforation 7. Features of focal neurologic deficit or meningeal irritation with fever 8. Unexplained mental changes with fever 9. Papular or nodular skin lesions 10. Intra-ocular evidence of systemic fungal infection 38
  • 39.
    Candidiasis • Usually opportunisticand endogenous originating from oropharyngeal, genitourinary or skin colonization • May be nosocomial Acute disseminated Chronic disseminated (hepatosplenic)
  • 41.
     Coccidiomycoses –caused by genus Coccidioides. • Primary respiratory infection. • Leads to fever, erythremia, and bronchial pneumonia. • Usually resolves spontaneously due to immune defense. • Some cases are fatal.
  • 43.
     Histoplasmosis –caused by Histoplasma capsulatum • Often associated with immunodeficiency. • Causes the formation of granulomas. • Can necrotize and become calcified. • If disseminated can be fatal.
  • 45.
     Aspergillosis –caused by several species of Aspergillus • Associated with immunodeficiency. • Can be invasive and disseminate to the blood and lungs  Causes acute pneumonia • Mortality is very high.  Death can occur in weeks.
  • 47.
  • 48.
    Etioliogical agent: Candidaalbicans • Dimorphic fungus of the class Deuteromycetes .  Grows as yeast or pseudohyphae  Spread by contact; often part of normal flora  Opportunistic infections common. Vulvovaginitis  Oral candidiasis (thrush)  Systemic candidiasis
  • 49.
    Candidiasis • Residing normallyin the skin, mouth, gastrointestinal tract, and vagina. • DIABETICS AND BURN PATIENTS susceptible to superficial candidiasis. • Severe disseminated candidiasis: commonly occurs in patients who are neutropenic due to Leukemia, Chemotherapy, Or Bone Marrow Transplantation, and may cause shock and DIC.
  • 50.
    Types of candidiasis Oralcandidiasis (Thrush). Perlèche (Angular cheilitis). Candidal vulvovaginitis . Diaper candidiasis. Congenital cutaneous candidiasis . Perianal candidiasis . Candidal paronychia . Erosio interdigitalis . Chronic mucocuntaneous candidiasis . Systemic candidiasis. Antibiotic candidiasis (Iatrogenic candidiasis)
  • 52.
     commonly candidiasistakes the form of a superficial infection on mucosal surfaces of the oral cavity (thrush):  Clinical features Oral thrush: it is a sore mouth, shows white curd like patches of the fungus on the oral mucosa and tongue, which can be scrapped away leaving a raw, tender, bleeding surface behind
  • 54.
    1. Topical antifungalagents Polyenes :Amphotericin B nystatin. Imidazoles: Clotrimazole Miconazole econazole  2. Systemic antifungal agents :triazoles Fluconazole , itraconazole
  • 55.
     Dermatomycoses areany fungal infection of the skin or hair.  Caused by many different species and are generally named after the infected area rather than the species that causes it.
  • 56.
    Cause: Several generaof dermatophytic fungi: • Trichophyton. • Microsporum. • Epidermophyton. • Grow on skin, hair, nails • Transmitted by contact with infected persons or animals.
  • 57.
    • Tinea pedis •Tinea corporis • Tinea capitis • Tinea barbae • Tinea cruris • Tinea unguium/onychomycosis Tinea infections: Red, scaly or blister-like lesions; often a raised red ring; “ringworm”
  • 60.
     TOPICAL THERAPY:should be applied for at least 2 weeks.  Topical azoles and allylamines high rates of clinical efficacy. (miconazole/ terbinafin)  These agents inhibit the synthesis of ergosterol, a major fungal cell membrane sterol.  SYSTEMIC THERAPY: may be indicated for tinea corporis in extensive skin infection, immunosuppression, resistance to topical antifungal therapy.
  • 61.
  • 62.